| scholarly article | Q13442814 |
| P50 | author | Kirsten Morley | Q57072925 |
| P2093 | author name string | Glenn E Hunt | |
| Iain S McGregor | |||
| Kirsten C Morley | |||
| Kong M Li | |||
| Clint G Gurtman | |||
| P2860 | cites work | Effects of 3,4-methylenedioxy-methamphetamine (MDMA) on anxiety in mice tested in the light-dark box. | Q51080404 |
| MDMA ('ecstasy') consumption in the context of polydrug abuse: a report on 150 patients. | Q51990374 | ||
| Working memory deficits in current and previous users of MDMA ('ecstasy'). | Q52026772 | ||
| A rapid method for the regional dissection of the rat brain | Q71341046 | ||
| MDMA (Ecstasy) neurotoxicity: assessing and communicating the risks | Q73837153 | ||
| Impaired cognitive performance in drug free users of recreational ecstasy (MDMA) | Q30495577 | ||
| Cognitive performance and serotonergic function in users of ecstasy. | Q32014191 | ||
| Toxicodynamics and long-term toxicity of the recreational drug, 3, 4-methylenedioxymethamphetamine (MDMA, 'Ecstasy'). | Q33864805 | ||
| Long term psychiatric and cognitive effects of MDMA use. | Q33864818 | ||
| Ecstasy (MDMA): a review of its possible persistent psychological effects | Q34098519 | ||
| Memory deficits associated with recreational use of "ecstasy" (MDMA). | Q34491716 | ||
| Behavioural, hyperthermic and neurotoxic effects of 3,4-methylenedioxymethamphetamine analogues in the Wistar rat. | Q40602429 | ||
| A comparison between Dark Agouti and Sprague-Dawley rats in their behaviour on the elevated plus-maze, open-field apparatus and activity meters, and their response to diazepam | Q40657914 | ||
| Hyperthermia following MDMA administration in rats: effects of ambient temperature, water consumption, and chronic dosing | Q40678302 | ||
| Spontaneous release of endogenous 5-hydroxytryptamine and 5-hydroxyindoleacetic acid from the isolated vascularly perfused ileum of the guinea-pig | Q42015813 | ||
| Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: immunocytochemical evidence for neurotoxicity. | Q42489289 | ||
| The use of social interaction as a method for detecting anxiolytic activity of chlordiazepoxide-like drugs | Q42664406 | ||
| Prior exposure to methylenedioxyamphetamine (MDA) induces serotonergic loss and changes in spontaneous exploratory and amphetamine-induced behaviors in rats | Q43627489 | ||
| Effects of dose, sex, and long-term abstention from use on toxic effects of MDMA (ecstasy) on brain serotonin neurons | Q43821407 | ||
| Increased anxiety and impaired memory in rats 3 months after administration of 3,4-methylenedioxymethamphetamine ("ecstasy"). | Q43832354 | ||
| 3,4-Methylenedioxymethamphetamine (MDMA) modulates cortical and limbic brain activity as measured by [H(2)(15)O]-PET in healthy humans | Q43842046 | ||
| Long-term changes in social interaction and reward following repeated MDMA administration to adolescent rats without accompanying serotonergic neurotoxicity | Q43874256 | ||
| A study of the effect of a single neurotoxic dose of 3,4-methylenedioxymethamphetamine (MDMA; "ecstasy") on the subsequent long-term behaviour of rats in the plus maze and open field | Q43893856 | ||
| MDMA-induced neurotoxicity: parameters of degeneration and recovery of brain serotonin neurons | Q48121118 | ||
| The distribution of 3,4-methylenedioxymethamphetamine "Ecstasy"-induced c-fos expression in rat brain | Q48149811 | ||
| 5-Hydroxytryptamine and punishment | Q48271813 | ||
| Memory impairment in abstinent MDMA ("Ecstasy") users | Q48327601 | ||
| The relationship between the degree of neurodegeneration of rat brain 5-HT nerve terminals and the dose and frequency of administration of MDMA ('ecstasy'). | Q48374881 | ||
| Small changes in ambient temperature cause large changes in 3,4-methylenedioxymethamphetamine (MDMA)-induced serotonin neurotoxicity and core body temperature in the rat. | Q48444036 | ||
| Locomotor response to MDMA is attenuated in knockout mice lacking the 5-HT1B receptor | Q48705199 | ||
| (+/-)-3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy') increases social interaction in rats. | Q51073688 | ||
| P433 | issue | 1-3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | serotonin | Q167934 |
| P304 | page(s) | 89-96 | |
| P577 | publication date | 2002-06-01 | |
| P1433 | published in | European Journal of Pharmacology | Q1376712 |
| P1476 | title | Increased anxiety in rats after 3,4-methylenedioxymethamphetamine: association with serotonin depletion | |
| P478 | volume | 446 |
| Q34565712 | 3,4-Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: a reappraisal of past and present findings |
| Q90357490 | 3,4-methylenedioxymethamphetamine (MDMA) impairs the extinction and reconsolidation of fear memory in rats |
| Q35851128 | A developmental comparison of the neurobehavioral effects of ecstasy (MDMA) |
| Q42951082 | Acute Effects of Ecstasy on Memory Are more Extensive than Chronic Effects |
| Q44885616 | Acute and long-term consequences of single MDMA administration in relation to individual anxiety levels in the rat. |
| Q37138642 | Alcohol Interactions with Psychostimulants: An Overview of Animal and Human Studies |
| Q35142554 | Behavioral and neurochemical effects of repeated MDMA administration during late adolescence in the rat |
| Q30466934 | Behavioral effects of MDMA ('ecstasy') on adult zebrafish. |
| Q55008359 | Brain Aromatase Modulates Serotonergic Neuron by Regulating Serotonin Levels in Zebrafish Embryos and Larvae. |
| Q35291205 | Chronic administration of THC prevents the behavioral effects of intermittent adolescent MDMA administration and attenuates MDMA-induced hyperthermia and neurotoxicity in rats. |
| Q25256989 | Chronic exposure to MDMA (Ecstasy) elicits behavioral sensitization in rats but fails to induce cross-sensitization to other psychostimulants |
| Q44662300 | Chronic fluoxetine treatment partly attenuates the long-term anxiety and depressive symptoms induced by MDMA ('Ecstasy') in rats |
| Q48909201 | Differential behavioural and neurochemical outcomes from chronic paroxetine treatment in adolescent and adult rats: a model of adverse antidepressant effects in human adolescents? |
| Q34645756 | Dissociation of the neurochemical and behavioral toxicology of MDMA ('Ecstasy') by citalopram |
| Q31033315 | Ecstasy: are animal data consistent between species and can they translate to humans? |
| Q46399265 | Ethanol, 3,4-methylenedioxymethamphetamine (ecstasy) and their combination: long-term behavioral, neurochemical and neuropharmacological effects in the rat. |
| Q44497121 | Hippocampal serotonergic damage induced by MDMA (ecstasy): effects on spatial learning |
| Q44407124 | Increased anxiety 3 months after brief exposure to MDMA ("Ecstasy") in rats: association with altered 5-HT transporter and receptor density |
| Q40561021 | Increased anxiety and "depressive" symptoms months after MDMA ("ecstasy") in rats: drug-induced hyperthermia does not predict long-term outcomes. |
| Q37113799 | Long-term behavioral consequences of prenatal MDMA exposure |
| Q40537975 | MDMA ("ecstasy"), methamphetamine and their combination: long-term changes in social interaction and neurochemistry in the rat. |
| Q34364144 | MDMA (N-methyl-3,4-methylenedioxyamphetamine) and its stereoisomers: Similarities and differences in behavioral effects in an automated activity apparatus in mice |
| Q48369774 | MDMA in adolescent male rats: decreased serotonin in the amygdala and behavioral effects in the elevated plus-maze test |
| Q37452207 | MDMA pretreatment leads to mild chronic unpredictable stress-induced impairments in spatial learning |
| Q44553347 | Methylenendioxyamphetamine produces serotonin nerve terminal loss and diminished behavioural and neurochemical responses to the antidepressant fluoxetine |
| Q24619949 | Neural and cardiac toxicities associated with 3,4-methylenedioxymethamphetamine (MDMA) |
| Q35010538 | Neurotoxicity of drugs of abuse--the case of methylenedioxyamphetamines (MDMA, ecstasy), and amphetamines |
| Q48242871 | Novel biochemical manipulation of brain serotonin reveals a role of serotonin in the circadian rhythm of sleep-wake cycles |
| Q44132900 | On the anxiogenic and anxiolytic nature of long-term cerebral 5-HT depletion following MDMA. |
| Q46970782 | Pre-treatment with 3,4-methylenedioxymethamphetamine (MDMA) causes long-lasting changes in 5-HT2A receptor-mediated glucose utilization in the rat brain |
| Q28577893 | Prenatal stress generates deficits in rat social behavior: Reversal by oxytocin |
| Q48405043 | Sex differences in the neurochemical and functional effects of MDMA in Sprague-Dawley rats |
| Q46411318 | Social interaction deficits caused by chronic phencyclidine administration are reversed by oxytocin |
| Q46970778 | The acute and long-term neurotoxic effects of MDMA on marble burying behaviour in mice |
| Q49264339 | The effect of 3,4- methylenedioxymethamphetamine on expression of neurotrophic factors in hippocampus of male rats |
| Q21558652 | The neurotoxicity of amphetamines during the adolescent period |
| Q36961251 | The sleep-wake cycle and motor activity, but not temperature, are disrupted over the light-dark cycle in mice genetically depleted of serotonin |
| Q36742799 | Treatment with a serotonin-depleting regimen of MDMA prevents conditioned place preference to sex in male rats |
Search more.